The iTBra™

  • sl1
  • sl4
  • sl3
  • sl2
  • sl1
  • sl4
  • sl3
  • sl2
rl

 

The iTBra™ is a wearable breast tissue abnormality screening tool and database. The device, called a Circadian Biometric Recorder (CBR), takes in thermodynamic data periodically from a woman’s breasts over a given time period. This data is then fed into a proprietary analytics software system. This software utilizes bioinformatics algorithms that are self-learning, continually improving patient outcome sensitivity, specificity, and accuracy.

About Lifeline Biotechnologies:
Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV.  LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer.  Three “Proof of Concept” clinical trials of over 500 women have been completed and three patents (one hardware, two software) have been awarded. 

Safe Harbor:
This publication includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, the ability to obtain financing, successful development of the Company's product or market acceptance of the product and regulatory and shareholder approval for anticipated actions.